Rare Variant and Epigenomic Analysis in ME/CFS
Dauer: 36 Monate, Fördersumme: € 999.169
Anticipating crisis measures and societal resilience to energy crises
Dauer: 12 Monate, Fördersumme: € 99.900
Predicting the evolution of relapse in Wilms tumour using drug sensitivity profiling and liquid biopsies
Fördersumme: € 999.538
Personalized risk assessment for embryonal tumor predisposition
Fördersumme: € 999.003
Functional Identification of Response Biomarkers to Advance Precision Oncology in Childhood Cancers
Fördersumme: € 999.357
Insights from Foresight and Analytics for Societal Resilience in Migration Crises
Dauer: 18 Monate, Fördersumme: € 99.242